BIOLOGICAL RESPONSE MODIFIERS IN MELANOMA

被引：12

作者：

BRIDGEWATER, JA

GORE, ME

机构：

[1] Department of Medicine, Royal Marsden Hospital, London

来源：

BRITISH MEDICAL BULLETIN | 1995年 / 51卷 / 03期

关键词：

D O I：

10.1093/oxfordjournals.bmb.a072985

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：656 / 677

页数：22

共 94 条

[61]

MEIR JW, 1993, THERAPEUTIC APPLICAT, V2, P455

[62] EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA [J].

MITCHELL, MS ;

KEMPF, RA ;

HAREL, W ;

SHAU, H ;

BOSWELL, WD ;

LIND, S ;

BRADLEY, EC .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :409-424

[63]

MUGHAL TI, 1991, ONCOLOGY, V48, P365

[64] PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY 14G2 A ADMINISTERED BY PROLONGED INTRAVENOUS-INFUSION IN PATIENTS WITH NEUROECTODERMAL TUMORS [J].

MURRAY, JL ;

CUNNINGHAM, JE ;

BREWER, H ;

MUJOO, K ;

ZUKIWSKI, AA ;

PODOLOFF, DA ;

KASI, LP ;

BHADKAMKAR, V ;

FRITSCHE, HA ;

BENJAMIN, RS ;

LEGHA, SS ;

ATER, JL ;

JAFFE, N ;

ITOH, K ;

ROSS, MI ;

BUCANA, CD ;

THOMPSON, L ;

CHEUNG, L ;

ROSENBLUM, MG .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :184-193

[65] INTERLEUKIN-2 THERAPY IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - A PHASE-II STUDY [J].

PARKINSON, DR ;

ABRAMS, JS ;

WIERNIK, PH ;

RAYNER, AA ;

MARGOLIN, KA ;

VANECHO, DA ;

SZNOL, M ;

DUTCHER, JP ;

ARONSON, FR ;

DOROSHOW, JH ;

ATKINS, MB ;

HAWKINS, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1650-1656

[66] ADJUVANT INTERFERON IN MELANOMA [J].

RETSAS, S .

LANCET, 1994, 343 (8911) :1498-1499

[67] SEQUENTIAL CHEMOIMMUNOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA [J].

RICHARDS, JM ;

MEHTA, N ;

RAMMING, K ;

SKOSEY, P .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) :1338-1343

[68] TREATMENT OF METASTATIC MALIGNANT-MELANOMA WITH RECOMBINANT INTERFERON ALPHA-2 [J].

ROBINSON, WA ;

MUGHAL, TI ;

THOMAS, MR ;

JOHNSON, M ;

SPIEGEL, RJ .

IMMUNOBIOLOGY, 1986, 172 (3-5) :275-282

[69] A PHASE-II STUDY OF COMBINED ADMINISTRATION OF DACARBAZINE AND CARBOPLATIN WITH HOME THERAPY OF RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2A IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA [J].

RON, IG ;

MORDISH, Y ;

EISENTHAL, A ;

SKORNICK, Y ;

INBAR, MJ ;

CHAITCHIK, S .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (06) :379-384

[70] PROSPECTIVE RANDOMIZED TRIAL OF HIGH-DOSE INTERLEUKIN-2 ALONE OR IN CONJUNCTION WITH LYMPHOKINE-ACTIVATED KILLER-CELLS FOR THE TREATMENT OF PATIENTS WITH ADVANCED CANCER [J].

ROSENBERG, SA ;

LOTZE, MT ;

YANG, JC ;

TOPALIAN, SL ;

CHANG, AE ;

SCHWARTZENTRUBER, DJ ;

AEBERSOLD, P ;

LEITMAN, S ;

LINEHAN, WM ;

SEIPP, CA ;

WHITE, DE ;

STEINBERG, SM .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (08) :622-632

← 1 2 3 4 5 6 7 8 9 10 →